Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Advancing Precision Equity With Multicancer Detection Liquid Biopsies | Synapse

August 1, 2024

Ver artículo completo

Advancing Precision Equity With Multicancer Detection Liquid Biopsies

NSNicholas P. SemenkovichMedical College of Wisconsin GAGautam AgarwalAugusta University ACAadel A. ChaudhuriMayo Clinic

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

This Viewpoint discusses the clinical and socioeconomic potential of multicancer detection liquid biopsies.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Semenkovich et al. (Thu,) studied this question.

synapsesocial.com/papers/68e5dfdcb6db643587574a11 https://doi.org/https://doi.org/10.1001/jamaoncol.2024.1860

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Disparities in Meeting USPSTF Breast, Cervical, and Colorectal Cancer Screening Guidelines Among Women in the United States2021 · 95 citations
2Evaluation of cell-free DNA approaches for multi-cancer early detection2022 · 316 citations
3Implementation of a multi-cancer early detection (MCED) test using a centralized model within (w/i) a multi-state health system.2023 · 3 citations
4Cell-free DNA approaches for cancer early detection and interception2023 · 84 citations
5Detection and characterization of lung cancer using cell-free DNA fragmentomes2021 · 478 citations